A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z|ALL

  检 索： 期刊名称 ISSN         高级检索

期刊名称：PHYTOTHERAPY RESEARCH ISSN： 0951-418X 版本： SCI-CDE 出版频率： Monthly 出版社： WILEY, 111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774   出版社网址： http://onlinelibrary.wiley.com/ 期刊网址： http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1099-1573 影响因子： 5.882 主题范畴： CHEMISTRY, MEDICINAL;    PHARMACOLOGY & PHARMACY 期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)    About the journal     Phytotherapy Research       Copyright © 2004 John Wiley & Sons, Ltd. Phytotherapy Research is a bimonthly, plus two additional issues, international journal for the publication of original medical plant research, including biochemistry and molecular pharmacology, toxicology, pathology, and the clinical applications of herbs and natural products to both human and animal medicine. Papers are also published concerning chemical and botanical identification of herbs or their products where such information contributes to the overall safety of plant based medicines currently in use. Papers and communications concerned solely with the identification and structure elucidation of natural products will only be considered where the work contributes directly to the understanding of the use of the plant as a medicine. Phytotherapy Research publishes full-length original research papers, short communications, reviews and letters on medicinal plant research. Clincal papers, on the applications of herbs and natural products to both human and animal medicine, may vary from case histories to full clinical trials. Papers concerned with the effects of common food ingredients and standardised plant extracts, including commercial products, are welcome, as are mechanistic studies on isolated natural products. Phytotherapy Research does not publish purely agricultural, phytochemical, structure elucidation and identification papers unless pertinent to the pharmacological effects, or overall safety of plant based medicines currently in use. Papers dealing with the pharmacology and screening of crude extracts often deal with local medicinal plants and are of only limited interest to an international readership. Therefore please consider carefully whether your paper would be more appropriate to a national journal before sending it to Phytotherapy Research. Crude extract papers will still be considered for publication as short communications, but only if they are a single published page in length (equivalent to 600 words, to include due allowance for any illustrations). Longer manuscripts will be returned without being reviewed. Abstracting and Indexing Services CAB Abstracts Cambridge Scientific Abstracts Chemical Abstracts Service Cumulative Index to Nursing & Allied Health Literature (CINAHL) Current Contents®/Life Sciences (ISI) Elsevier BIOBASE/Current Awareness in Biological Sciences EMBASE/Excerpta Medica (Elsevier) Index Medicus/MEDLINE ISI Alerting Services Natural Products Update (RSC) Science Citation Index Expanded (also known as SciSearch®) (ISI) Science Citation Index® (ISI) Instructions to Authors Phytotherapy Research is a bimonthly, plus two additional issues, international journal for the publication of original medical plant research, including biochemistry and molecular pharmacology, toxicology, pathology, and the clinical applications of herbs and natural products to both human and animal medicine. Papers are also published concerning chemical and botanical identification of herbs or their products where such information contributes to the overall safety of plant based medicines currently in use. Papers and communications concerned solely with the identification and structure elucidation of natural products will only be considered where the work contributes directly to the understanding of the use of the plant as a medicine. Phytotherapy Research publishes full-length original research papers, short communications, reviews and letters on medicinal plant research. Clincal papers, on the applications of herbs and natural products to both human and animal medicine, may vary from case histories to full clinical trials. Papers concerned with the effects of common food ingredients and standardised plant extracts, including commercial products, are welcome, as are mechanistic studies on isolated natural products. Phytotherapy Research does not publish purely agricultural, phytochemical, structure elucidation and identification papers unless pertinent to the pharmacological effects, or overall safety of plant based medicines currently in use. Papers dealing with the pharmacology and screening of crude extracts often deal with local medicinal plants and are of only limited interest to an international readership. Therefore please consider carefully whether your paper would be more appropriate to a national journal before sending it to Phytotherapy Research. Crude extract papers will still be considered for publication as short communications, but only if they are a single published page in length (equivalent to 600 words, to include due allowance for any illustrations). Longer manuscripts will be returned without being reviewed. Initial Manuscript Submission. Submit three copies of the manuscript (including copies of tables and illustrations) to Dr E.M. Williamson, PTR Editorial Office, The School of Pharmacy, University of London, 29/39 Brunswick Square, London WC1N 1AX, UK or to Dr Larry A. Walker, National Center for Natural Products Research, School of Pharmacy, The University of Mississippi University, MS 38677, USA. Authors must also supply: an electronic copy of the final version (see section below), a Copyright Transfer Agreement with original signature(s) - without this we are unable to accept the submission, and permission grants - if the manuscript contains extracts, including illustrations, from other copyright works (including material from on-line or intranet sources) it is the author's responsibility to obtain written permission from the owners of the publishing rights to reproduce such extracts using the Wiley Permission Request Form. Permission grants should be submitted with the manuscript. Submitted manuscripts should not have been previously published and should not be submitted for publication elsewhere while they are under consideration by Wiley. Submitted material will not be returned to the author unless specifically requested. To facilitate the review process. authors may supply details of up to three reviewers who may be contacted at the discretion of the Editors. Electronic Submission. The electronic copy of the final, revised manuscript must be sent to the Editor together with the paper copy. Disks should be PC or Mac formatted; write on the disk the software package used, the name of the author and the name of the journal. We are able to use most word processing packages, but prefer Word or WordPerfect Illustrations must be submitted in electronic format where possible. Save each figure as a separate file, in TIFF or EPS format preferably, and include the source file. Write on the disk the software package used to create them; we favour dedicated illustration packages over tools such as Excel or Powerpoint. Manuscript Style. The language of the journal is English. Please ensure that your manuscript has been checked by an English language expert if there is concern for grammatical or other errors. All submissions including book reviews must have a title, be printed on one side of the paper, be double-line spaced with type no smaller than 12 point, and have a margin of 3cm all round. Illustrations and tables must be printed on separate sheets, and not be incorporated into the text. The title page must list the full title, short title of up to 60 characters and names and affiliations of all authors. Give the full address, including email, telephone and fax, of the author who is to check the proofs. Include the name(s) of any sponsor(s) of the research contained in the paper, along with grant number(s). Supply an abstract of up to 200 words for all articles. An abstract is a concise summary of the whole paper, not just the conclusions, and is understandable without reference to the rest of the paper. It should contain no citation to other published work. Include up to six keywords that describe your paper for indexing purposes. Authors may suggest 5 potential reviewers A concise introduction is required of the background to the subject, its significance and its relationship to earlier works, with references. Materials and methods should be presented with clarity and detail. State the original and important findings in the results. Illustrate these with figures or tables where necessary but keep these to a minimum. Results and discussion may be combined as one section. Discuss the principal conclusions drawn from the results and their important implications. Convention on biodiversity. Authors must indicate that they have obtained authority to access plant samples (other than freely available commercial crops or herbal products) used for research and that this has been authorised by the appropriate agent of the government of the source country as required under the framework of the United Nations Convention on Biodiversity. Botanical aspects. Plant materials used must be adequately described using the Latin binomial for the plant, author of the name, plant family, source (e.g. country and region of collection, name of the collector and collection number) means of unambiguous identification (e.g. name and affiliation of expert botanist or the results of comparison with a published monograph and/or authenticated reference specimen). The reference number and place of deposition of a voucher specimen of the plant material must be given. For papers relating to crude plant extracts, the method of extraction and the yield of dried extract as a percentage weight of the starting fresh or dried plant material must also be stated. In general these are preferred as short communications (see below). Experimental procedures. Bioassay data for plant extracts or isolated compounds must be accompanied by data for positive and negative controls. All animal experiments should be conducted in accordance with the UK Animals (Scientific Procedures) Act 1986 and associated guidelines, the EEC Directive of 1986 (86/609/EEC) or the NIH guide for the care and use of laboratory animals (NIH Publication No. 80-23; revised 1978). The Editors will reject papers if there is any doubt about the suitability of the animal procedures used. Use Chemical Abstracts nomenclature for chemical names and structures. Use proper or proprietary names with caution. Common acronyms for biomedical names are acceptable but define all others when first mentioned. Define abbreviations when first mentioned and do not use in the title or abstract. Define non-standard units. Keep acknowledgements brief and place them at the end of the paper. Original Papers. These should not exceed five printed papers including a maximum of four figures and/or four tables and 30 references, (where one page comprises 800 words or the equivalent in illustrative and tabular material). Short Communications. These must be complete, self-contained papers, and not preliminary reports. These should not exceed two printed pages including a maximum of two figures and/or two tables and 10 references. To exceed the limit may delay acceptance or publication of the paper. Reviews and Keynote Lecture Transcripts. These will usually be written at the invitation of the Editors. Unsolicited reviews and manuscripts based on Conference Keynote Lectures will be welcome but authors wishing to submit these are requested to consult the Reviews Editor beforehand, ideally prior to commencement of writing. Reviews should include a Table of Contents and will normally be limited to 10,000 words including references. Submissions to: Dr A Raman, Department of Pharmacy, King's College London, The Franklin-Wilkins Building, 150 Stamford St, London SE1 8WA, UK. Correspondence. Items submitted for the correspondence columns, which need have no fixed format are intended for constructive comments on published work or for putting forward new ideas and are published at the discretion of the Editors. Reference style. References should be quoted in the text as name and year, and listed at the end of the paper alphabetically. All references must be complete and accurate. Phytotherapy Research uses Index Medicus Style abbreviations for journals cited. For correct abbreviations visit http://www.ncbi.nlm.nih.gov/entrez/jrbrowser.cgi. If necessary, cite unpublished or personal work in the text but do not include it in the reference list. References should be listed in the following style: Journals: Wright CW, Phillipson JD. 1990. Natural products and the development of selective antiprotozoal drugs. Phytother Res 4: 127-139. Books: Wagner H, Bladt S. 1996. Plant Drug Analysis: A Thin Layer Chromatography Atlas (2nd edn). Springer-Verlag: Berlin Heidelberg. Chapters in Books: Kips RH. 1985. Environmental aspects. In Pesticide Application: Principles and Practice, Haskel PT (ed). Oxford University Press: Oxford; 1-34. Illustrations. Supply each illustration on a separate sheet. Write the lead author's name and the figure number on the reverse and make sure the top is clearly indicated. Supply original photographs; photocopies or previously printed material will not be used. Line artwork must be high-quality laser output (not photocopies). Tints are not acceptable. Lettering must be of a reasonable size that would still be clearly legible upon reduction, and consistent within each figure and set of figures. Please supply artwork at the intended size for printing, sized to the text width of 84mm/single column, 176mm/double column. The cost of printing colour illustrations in the journal will be charged to the author. If colour illustrations are supplied electronically in either TIFF or EPS format, they may be used in the PDF of the article at no cost to the author, even if this illustration was printed in black and white in the journal. The PDF will appear on the Wiley InterScience site. Copyright. To enable the publisher to disseminate the author's work to the fullest extent, the author must sign a Copyright Transfer Agreement, transferring copyright in the article from the author to the publisher, and submit the original signed agreement with the article presented for publication. A copy of the agreement to be used (which may be photocopied) can be found in the first issue of each volume of Phytotherapy Research. Copies may also be obtained from the journal editor or publisher, or may be printed from this website. Further Information. Proofs will be sent to the author for checking. This stage is to be used only to correct errors that may have been introduced during the production process. Prompt return of the corrected proofs, preferably within two days of receipt, will minimise the risk of the paper being held over to a later issue. 25 complimentary offprints will be provided to the author who checked the proofs, unless otherwise indicated. Further offprints and copies of the journal may be ordered. There is no page charge to authors. Editorial Board EDITOR-IN-CHIEF Elizabeth M. Williamson Department of Pharmacognosy, The School of Pharmacy, University of London, 29/39 Brunswick Square, London WC1N 1AX, UK Fax: +44 20 7753 5909 E-mail: phytotherapy.research@ams1.ulsop.ac.uk EDITOR Andy Constanti Department of Pharmacology The School of Pharmacy University of London 29/39 Brunswick Square London WC1N 1AX, UK Fax: +44 20 7753 5909 FOUNDING EDITOR Fred J. Evans ASSISTANT EDITOR Anita Bhoomkar EDITORIAL ADMINISTRATOR Rachael Bilginer EDITORIAL BOARD K. Asres Addis Ababa University, Addis Ababa, Ethiopia J. Barnes University of London, London, UK S. K. Bhattacharya Benares Hindu University Varanasi, India K.J. Broadley University of Wales, Cardiff, UK F. Bucar University of Graz, Graz, Austria F. Capasso University of Naples, Naples, Italy E.A. Carlini Universidade Federal de São Paulo, São Paulo, Brazil K.L. Chan University of Sains Malaysia, Penang, Malaysia C.-T. Che The Chinese University of Hong Kong, Hong Kong S. Gibbons University of London, UK O. Gulati Horphag Research Management, Geneva, Switzerland J.P. Heggers Shriners Hospital for Children, Galveston, TX, USA M. Iwu University of Nigeria, Nsukka, Nigeria W.J. Keller Samford University, Birmingham, AL, USA I.A. Khan National Center for Natural Products Research, MS, USA A.D. Kinghorn College of Pharmacy, Chicago, IL, USA M. Lis-Balchin South Bank University, London, UK B.V. Manyam Texas A&M University College of Medicine, TX, USA A.M. Mastro Pennsylvania State University, PA, USA P.K. Mukherjee Jadavpur University, Kolkata, India D.T. Okpako University of Ibadan, Ibadan, Nigeria J.M. Pezzuto University of Illinois at Chicago, Chicago, IL, USA A.-F. Rizk Qatar University, Doha, Qatar W. Schneider Lichtwer Pharm AG, Berlin, Germany R.D.E. Sewell University of Wales, Cardiff, UK D. Shaw Guys and St Thomas' Hospital Trust, London, UK Y. Shoyama Kyushu University, Fukuoka, Japan M. Simmonds Royal Botanical Gardens, Kew, UK P.A.G.M. De Smet Scientific Institute of Dutch Pharmacists, The Hague, The Netherlands N. Snell Bayer Pharmaceuticals, Slough, UK R.C. Srimal Industrial Toxicology Research Centre, Lucknow, India D. Staneva Institute of Physiology, Sofia, Bulgaria A.J. Vlietinck University of Antwerp, Antwerp, Belgium P.G. Waterman Southern Cross University, Lismore, NSW, Australia W.D. Winters University of Texas Health, Science Center, USA C. Wright University of Bradford, Bradford, UK S.-L. Yang Institute of Medicinal Plant Development, Beijing, China